NO332942B1 - Inhalator - Google Patents
InhalatorInfo
- Publication number
- NO332942B1 NO332942B1 NO20022545A NO20022545A NO332942B1 NO 332942 B1 NO332942 B1 NO 332942B1 NO 20022545 A NO20022545 A NO 20022545A NO 20022545 A NO20022545 A NO 20022545A NO 332942 B1 NO332942 B1 NO 332942B1
- Authority
- NO
- Norway
- Prior art keywords
- delivery device
- measuring
- truncated cone
- bowls
- inhaler
- Prior art date
Links
- 239000003814 drug Substances 0.000 claims abstract description 57
- 239000000463 material Substances 0.000 claims abstract description 9
- 229940112141 dry powder inhaler Drugs 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims description 56
- 238000000034 method Methods 0.000 abstract description 5
- 208000014181 Bronchial disease Diseases 0.000 abstract description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 description 7
- 238000012377 drug delivery Methods 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 4
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 3
- -1 fermoterol Chemical compound 0.000 description 3
- 229960002714 fluticasone Drugs 0.000 description 3
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229960004017 salmeterol Drugs 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 2
- 229940124630 bronchodilator Drugs 0.000 description 2
- 239000000168 bronchodilator agent Substances 0.000 description 2
- 229960004436 budesonide Drugs 0.000 description 2
- 230000000881 depressing effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- VQDBNKDJNJQRDG-UHFFFAOYSA-N Pirbuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1 VQDBNKDJNJQRDG-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 229940125388 beta agonist Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 229960000676 flunisolide Drugs 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
- 229960004398 nedocromil Drugs 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- RLANKEDHRWMNRO-UHFFFAOYSA-M oxtriphylline Chemical compound C[N+](C)(C)CCO.O=C1N(C)C(=O)N(C)C2=C1[N-]C=N2 RLANKEDHRWMNRO-UHFFFAOYSA-M 0.000 description 1
- 229960005414 pirbuterol Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 1
- 229960002720 reproterol Drugs 0.000 description 1
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 1
- 229960001457 rimiterol Drugs 0.000 description 1
- IYMMESGOJVNCKV-SKDRFNHKSA-N rimiterol Chemical compound C([C@@H]1[C@@H](O)C=2C=C(O)C(O)=CC=2)CCCN1 IYMMESGOJVNCKV-SKDRFNHKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928265.9A GB9928265D0 (en) | 1999-12-01 | 1999-12-01 | Inhaler |
PCT/GB2000/004623 WO2001039823A1 (en) | 1999-12-01 | 2000-12-01 | Inhaler |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20022545L NO20022545L (no) | 2002-05-29 |
NO20022545D0 NO20022545D0 (no) | 2002-05-29 |
NO332942B1 true NO332942B1 (no) | 2013-02-04 |
Family
ID=10865413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022545A NO332942B1 (no) | 1999-12-01 | 2002-05-29 | Inhalator |
Country Status (18)
Country | Link |
---|---|
US (1) | US6845772B2 (es) |
EP (2) | EP1300171A3 (es) |
JP (1) | JP4674027B2 (es) |
AT (1) | ATE261326T1 (es) |
AU (1) | AU782118B2 (es) |
BR (1) | BR0016085A (es) |
CA (1) | CA2390791C (es) |
DE (1) | DE60008914T9 (es) |
DK (1) | DK1233805T3 (es) |
ES (1) | ES2217008T3 (es) |
GB (1) | GB9928265D0 (es) |
IL (2) | IL149623A0 (es) |
MX (1) | MXPA02005279A (es) |
NO (1) | NO332942B1 (es) |
NZ (1) | NZ518827A (es) |
PT (1) | PT1233805E (es) |
WO (1) | WO2001039823A1 (es) |
ZA (1) | ZA200203764B (es) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU742962B2 (en) * | 1998-01-30 | 2002-01-17 | Mibe Gmbh Arzneimittel | Inhalation apparatus for powder medications |
FI107126B (fi) * | 1999-04-23 | 2001-06-15 | Orion Yhtymae Oyj | Jauheinhalaattori yhdistelmälääkkeelle |
FI108518B (fi) * | 1999-04-23 | 2002-02-15 | Orion Yhtymae Oyj | Jauheinhalaattori yhdistelmälääkkeelle |
WO2000074754A2 (en) * | 1999-06-05 | 2000-12-14 | Innovata Biomed Limited | Delivery system |
GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
DE19961300A1 (de) * | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
US7103245B2 (en) | 2000-07-10 | 2006-09-05 | Massachusetts Institute Of Technology | High density integrated optical chip |
ES2291452T3 (es) * | 2001-02-06 | 2008-03-01 | Innovata Biomed Limited | Formulacion bimodal de polvo seco para inhalacion. |
GB0111337D0 (en) | 2001-05-10 | 2001-07-04 | Innovata Biomed Ltd | Device |
FI20011317A0 (fi) * | 2001-06-20 | 2001-06-20 | Orion Corp | Jauheinhalaattori |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
GB0128148D0 (en) * | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
EP1467790A1 (en) * | 2002-01-25 | 2004-10-20 | Glaxo Group Limited | Medicament dispenser |
GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
GB0217199D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
US6889690B2 (en) * | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
JP2005533581A (ja) * | 2002-07-25 | 2005-11-10 | グラクソ グループ リミテッド | 薬剤ディスペンサ |
GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
DE10300032B3 (de) * | 2003-01-03 | 2004-05-27 | E. Braun Gmbh | Pulverinhalator |
SE527191C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av tiotropium och fluticason |
SE527069C2 (sv) * | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
SE526850C2 (sv) * | 2003-06-19 | 2005-11-08 | Microdrug Ag | Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd |
GB0317374D0 (en) | 2003-07-24 | 2003-08-27 | Glaxo Group Ltd | Medicament dispenser |
US7451761B2 (en) * | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
US7377277B2 (en) * | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
ITMO20040060A1 (it) * | 2004-03-18 | 2004-06-18 | Roberto Oliva | Inalatore per preparati in polvere |
BRPI0509348A (pt) * | 2004-04-21 | 2007-09-11 | Innovata Biomed Ltd | inalador |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
GB0418278D0 (en) | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Medicament dispenser |
WO2006031712A2 (en) | 2004-09-13 | 2006-03-23 | Oriel Therapeutics, Inc. | Tubular dry powder drug containment systems, associated inhalers and methods |
GB0427853D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
GB0427858D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
WO2006119766A1 (en) * | 2005-05-10 | 2006-11-16 | Bang & Olufsen Medicom A/S | Forward metering valve |
GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
DE102005046645B3 (de) * | 2005-09-29 | 2006-07-20 | Braunform Gmbh | Pulverinhalator |
AR058290A1 (es) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Dispensador de medicamento |
AR058289A1 (es) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
US7832395B2 (en) * | 2006-03-09 | 2010-11-16 | Oxygen Plus, Inc. | Portable oxygen delivery apparatus |
JP2009543658A (ja) * | 2006-07-14 | 2009-12-10 | アストラゼネカ・アクチエボラーグ | 乾燥粉末状の薬を投与するための吸入装置及び配送装置 |
GB0622827D0 (en) | 2006-11-15 | 2006-12-27 | Glaxo Group Ltd | Sheet driver for use in a drug dispenser |
DE102007017725A1 (de) * | 2007-04-16 | 2008-10-23 | Astrazeneca Ab | Inhalator für pulverförmige Substanzen |
EP2058025B1 (en) * | 2007-11-09 | 2014-09-03 | Hitachi Ltd. | Powder medicine administering apparatus |
US8790366B2 (en) * | 2007-11-13 | 2014-07-29 | Alcon Research, Ltd. | Fan-shaped cannula for sealing ophthalmic incisions |
ES2394589T3 (es) | 2007-12-14 | 2013-02-04 | Aerodesigns, Inc | Suministro de productos alimenticios transformables en aerosol |
GB0800457D0 (en) * | 2008-01-11 | 2008-02-20 | Innovata Biomed Ltd | Improvements in or relating to inhalers |
GB0800459D0 (en) * | 2008-01-11 | 2008-02-20 | Innovata Biomed Ltd | Improvements in or relating to inhalers |
GB0912373D0 (en) | 2009-07-16 | 2009-08-26 | Innovata Biomed Ltd | Improvements in or relating to dry powder inhalers |
WO2011066107A1 (en) | 2009-11-24 | 2011-06-03 | Gilead Sciences, Inc. | Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
WO2011077414A2 (en) * | 2009-12-26 | 2011-06-30 | D.P.I Advanced Medical Technologies Ltd. | Dry powder delivery device |
US8367829B2 (en) | 2010-05-10 | 2013-02-05 | Gilead Sciences, Inc. | Bi-functional pyrazolopyridine compounds |
CA2796826A1 (en) | 2010-05-10 | 2011-11-17 | Gilead Sciences, Inc. | Bifunctional quinoline derivatives |
WO2012154483A1 (en) | 2011-05-06 | 2012-11-15 | Gilead Sciences, Inc. | Dry powder fosfomycin/tobramycin formulation for inhalation |
AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
GB2498746A (en) | 2012-01-26 | 2013-07-31 | Innovata Biomed Ltd | Inhaler which locks when empty |
US20150010527A1 (en) | 2012-02-01 | 2015-01-08 | Protalix Ltd. | Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy |
GB2499597A (en) | 2012-02-21 | 2013-08-28 | Innovata Biomed Ltd | Dry powder inhaler with stepped rotation of metering member |
MY171122A (en) | 2012-05-29 | 2019-09-26 | Parion Sciences Inc | Dendrimer like amino amides processing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
ES2674665T3 (es) | 2012-12-17 | 2018-07-03 | Parion Sciences, Inc. | Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida |
DK2931713T3 (en) | 2012-12-17 | 2017-01-30 | Parion Sciences Inc | CHLORPYRAZINE CARBOXAMIDE DERIVATIVES USED FOR THE TREATMENT OF DISEASES BENEFITED BY INDEPENDENT MOSPHEREWIN |
US9029382B2 (en) | 2012-12-17 | 2015-05-12 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds |
DE102014005646B4 (de) * | 2014-01-30 | 2016-05-12 | Klaus-Dieter Beller | Pulverinhalator und Pulverinhalationsset |
DE102014005647B4 (de) * | 2014-01-30 | 2016-05-12 | Klaus-Dieter Beller | Pulverinhalator und Pulverinhalatorset |
SE538400C2 (sv) * | 2014-04-03 | 2016-06-14 | Iconovo Ab | Torrpulverinhalator |
WO2016057693A1 (en) | 2014-10-10 | 2016-04-14 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for inhalation delivery of conjugated oligonucleotide |
USD767112S1 (en) * | 2015-04-15 | 2016-09-20 | K&N Engineering, Inc. | Vent breather |
KR200482260Y1 (ko) * | 2015-05-22 | 2017-01-04 | 동국대학교 산학협력단 | 선택적 약제배출 용기 |
GB202004831D0 (en) * | 2020-04-01 | 2020-05-13 | Ondosis Ab | Delivery device for oral dosage forms |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2346730C3 (de) | 1973-09-17 | 1980-10-16 | Carl Heyer Gmbh, Inhalationstechnik, 5427 Bad Ems | Einrichtung zur Aerosolbehandlung von Menschen, Tieren, Gegenständen, Stoffen u.dgl. in einem Behandlungsraum |
US5007419A (en) * | 1989-09-25 | 1991-04-16 | Allan Weinstein | Inhaler device |
US5002048A (en) * | 1989-12-12 | 1991-03-26 | Makiej Jr Walter J | Inhalation device utilizing two or more aerosol containers |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
GB9026025D0 (en) * | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
GB9203761D0 (en) * | 1992-02-21 | 1992-04-08 | Innovata Biomed Ltd | Inhaler |
US5437267A (en) * | 1993-08-03 | 1995-08-01 | Weinstein; Allan | Device for delivering aerosol to the nasal membranes and method of use |
US5524613A (en) * | 1993-08-25 | 1996-06-11 | Habley Medical Technology Corporation | Controlled multi-pharmaceutical inhaler |
US5664557A (en) * | 1994-03-10 | 1997-09-09 | Respiratory Delivery Systems, Inc. | Releasably engageable coupling for an inhaler |
DE19523516C1 (de) * | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen |
US6234167B1 (en) * | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6196218B1 (en) * | 1999-02-24 | 2001-03-06 | Ponwell Enterprises Ltd | Piezo inhaler |
FI108518B (fi) * | 1999-04-23 | 2002-02-15 | Orion Yhtymae Oyj | Jauheinhalaattori yhdistelmälääkkeelle |
US6543443B1 (en) * | 2000-07-12 | 2003-04-08 | Aerogen, Inc. | Methods and devices for nebulizing fluids |
US6523536B2 (en) * | 2001-03-12 | 2003-02-25 | Birdsong Medical Devices, Inc. | Dual-canister inhaler having a spacer and easy to operate lever mechanism |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
-
1999
- 1999-12-01 GB GBGB9928265.9A patent/GB9928265D0/en not_active Ceased
-
2000
- 2000-12-01 EP EP03075040A patent/EP1300171A3/en not_active Withdrawn
- 2000-12-01 CA CA002390791A patent/CA2390791C/en not_active Expired - Fee Related
- 2000-12-01 ES ES00985459T patent/ES2217008T3/es not_active Expired - Lifetime
- 2000-12-01 MX MXPA02005279A patent/MXPA02005279A/es active IP Right Grant
- 2000-12-01 NZ NZ518827A patent/NZ518827A/en not_active IP Right Cessation
- 2000-12-01 WO PCT/GB2000/004623 patent/WO2001039823A1/en active IP Right Grant
- 2000-12-01 EP EP00985459A patent/EP1233805B1/en not_active Expired - Lifetime
- 2000-12-01 AT AT00985459T patent/ATE261326T1/de active
- 2000-12-01 BR BR0016085-7A patent/BR0016085A/pt not_active IP Right Cessation
- 2000-12-01 PT PT00985459T patent/PT1233805E/pt unknown
- 2000-12-01 JP JP2001541553A patent/JP4674027B2/ja not_active Expired - Fee Related
- 2000-12-01 AU AU21878/01A patent/AU782118B2/en not_active Ceased
- 2000-12-01 DE DE60008914T patent/DE60008914T9/de active Active
- 2000-12-01 DK DK00985459T patent/DK1233805T3/da active
- 2000-12-01 IL IL14962300A patent/IL149623A0/xx active IP Right Grant
- 2000-12-01 US US10/148,288 patent/US6845772B2/en not_active Expired - Fee Related
-
2002
- 2002-05-10 ZA ZA200203764A patent/ZA200203764B/xx unknown
- 2002-05-13 IL IL149623A patent/IL149623A/en not_active IP Right Cessation
- 2002-05-29 NO NO20022545A patent/NO332942B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60008914T9 (de) | 2005-06-23 |
EP1233805B1 (en) | 2004-03-10 |
US6845772B2 (en) | 2005-01-25 |
MXPA02005279A (es) | 2003-09-22 |
EP1300171A2 (en) | 2003-04-09 |
US20030116157A1 (en) | 2003-06-26 |
ATE261326T1 (de) | 2004-03-15 |
DE60008914T2 (de) | 2005-03-10 |
BR0016085A (pt) | 2002-08-06 |
WO2001039823A1 (en) | 2001-06-07 |
GB9928265D0 (en) | 2000-01-26 |
DK1233805T3 (da) | 2004-07-12 |
AU782118B2 (en) | 2005-07-07 |
CA2390791C (en) | 2009-02-03 |
PT1233805E (pt) | 2004-07-30 |
ZA200203764B (en) | 2004-01-28 |
IL149623A0 (en) | 2002-11-10 |
NO20022545L (no) | 2002-05-29 |
EP1300171A3 (en) | 2003-08-13 |
JP2003515396A (ja) | 2003-05-07 |
DE60008914D1 (de) | 2004-04-15 |
CA2390791A1 (en) | 2001-06-07 |
NO20022545D0 (no) | 2002-05-29 |
ES2217008T3 (es) | 2004-11-01 |
EP1233805A1 (en) | 2002-08-28 |
NZ518827A (en) | 2005-06-24 |
JP4674027B2 (ja) | 2011-04-20 |
IL149623A (en) | 2007-07-24 |
AU2187801A (en) | 2001-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO332942B1 (no) | Inhalator | |
AU760750B2 (en) | Powder inhaler for combined medicament | |
US7571723B2 (en) | Delivery device | |
DE60019920T2 (de) | Verabreichungsystem für medikamente | |
NO331553B1 (no) | Innandingsapparat for kombinert legemiddel | |
EP2043717A1 (en) | Inhalation system and delivery device for the administration of a drug in the form of dry powder | |
HU189154B (en) | Feeding inhaler | |
NO320789B1 (no) | Inhalasjonsanordning med en doseringstelleenhet | |
NO320500B1 (no) | Pulverinhalator og fremgangsmate for a konstruere en slik | |
WO2002089882A1 (en) | Gauge | |
ZA200109579B (en) | Delivery system. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |